Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control
Conditions: Type2diabetes Interventions: Drug: Insulin Glargine 100 UNT/ML Pen Injector [Lantus]; Drug: Saxagliptin 2.5 mg/ Metformin Hydrochloride extended release 1000 mg; Drug: Pioglitazone 30mg Sponsors: University of Basrah Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Actos | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Insulin | Lantus | Metformin | Research